PrEP for Adolescents at Risk for HIV

Experts discuss new findings supporting the need for PrEP in adolescents and discuss the continued debate surrounding parental consent and other relevant issues.

Risk Factors of Neurocognitive Decline in HIV+ Individuals

The incidence of neurocognitive impairment is high in HIV-infected population, despite the introduction of combination antiretroviral therapy (CART).

Understanding Why Patients Discontinue ART and Increasing Adherence

Learn more about when stopping antiretroviral therapy (ART) may be necessary, why patients discontinue ART, predicting viral suppression, and predicting and encouraging adherence.

Bone Loss and Fracture Risk in Patients With HIV

In addition to prevention measures, switching off the ARTs associated with bone loss and administering intravenous bisphosphonate, a bone resorption inhibitor, can be an effective ...

Expert Insights on Aging With HIV

Three HIV experts provide their insights into aging-related challenges and complications faced by people living with HIV.

ART and PrEP: How Technological Advances Can Improve Adherence

Several technological advances have been developed to improve adherence to ART and PrEP.

Community Perspective on HIV Research at the End of Life

Dr Sara Gianella Weibel talks with Jeff Taylor, community activist and long-term HIV survivor, about a new end-of-life model to study HIV persistence.

Latest News

Tenofovir Use Safe During Pregnancy

Tenofovir Use Safe During Pregnancy

Further research on longer-term effects of maternal prenatal TDF use is important given the majority of HIV-infected women are prescribed a TDF-containing prevention of mother-to-child transmission regimen.

Dual Regimen Provides Simple and Safe Salvage Therapy in HIV-1

Dual Regimen Provides Simple and Safe Salvage Therapy in HIV-1

Switching to dolutegravir plus darunavir/ritonavir provided a simple and safe rescue regimen, controlling viral replication in a high proportion of patients.

Effectiveness of Ledipasvir/Sofosbuvir for Acute HCV Infection in HIV

Effectiveness of Ledipasvir/Sofosbuvir for Acute HCV Infection in HIV

Study evaluated the optimal duration of ledipasvir/sofosbuvir for the treatment of acute hepatitis C virus (HCV) infection in HIV.

Carotid Plaque, Risk of Vascular Disease Events Higher in HIV

Carotid Plaque, Risk of Vascular Disease Events Higher in HIV

Findings show that HIV status was associated with an increased rate of incidental carotid plaque, noncalcified plaque, and high-risk plaque.

Reduced Risk of Hepatic Steatosis in HIV/HCV Coinfection With Cannabis Use

Reduced Risk of Hepatic Steatosis in HIV/HCV Coinfection With Cannabis Use

Daily cannabis use remained significantly associated with lower odds of steatosis even after adjustment for BMI, which is known to be inversely correlated with cannabis use.

Efficacy of Maraviroc-Containing HIV PrEP in Women Evaluated

Efficacy of Maraviroc-Containing HIV PrEP in Women Evaluated

Maraviroc (MVC)-containing HIV PrEP regimens are well tolerated for preventing HIV infection in uninfected women.

CDC Contraception Recommendations Updated for Women at Risk for HIV

CDC Contraception Recommendations Updated for Women at Risk for HIV

Women should not be denied the use of progestin-only injectables because of concerns about the possible increased risk of acquiring HIV.

Once-Daily Raltegravir Safe, Effective for Initial HIV Treatment

Once-Daily Raltegravir Safe, Effective for Initial HIV Treatment

Once-daily regimens have been shown to improve adherence to treatment with no adverse effect on outcomes in patients with HIV.

Improving Linkage to Care in HIV Testing for Women

Improving Linkage to Care in HIV Testing for Women

Many women who are newly diagnosed with HIV have already been diagnosed but are not getting HIV medical care.

Pre-Exposure Prophylaxis Program for MSM Cost-Effective in UK

Pre-Exposure Prophylaxis Program for MSM Cost-Effective in UK

HIV PrEP in the UK for men who have sex with men might be cost-effective.

Feature Article

Amphotericin and Flucytosine Safe, Effective for HIV-Associated Cryptococcal Meningitis

Amphotericin and Flucytosine Safe, Effective for HIV-Associated Cryptococcal Meningitis

One-week amphotericin plus flucytosine was found to have comparable efficacy and safety profiles as the standard of care, 2-weeks amphotericin-based therapy, for treatment of HIV-associated cryptococcal meningitis in African patients.

ART and PrEP: How Technological Advances Can Improve Adherence

ART and PrEP: How Technological Advances Can Improve Adherence

Several technological advances have been developed to improve adherence to antiretroviral and preexposure prophylaxis therapy.

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Last Gift Study: A Participant's Perspective on End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Anthony B, a patient with HIV and end-stage amyotrophic lateral sclerosis and the first participant enrolled in the "Last Gift" end-of-life study, about his experience as part of this new end-of-life model to study HIV persistence.

Last Gift Study: End-of-Life HIV Research

Last Gift Study: End-of-Life HIV Research

Dr Sara Gianella Weibel talks with Dr Davey Smith, head of the Division of Infectious Disease at the University of California, San Diego, about a proposed new model to study HIV persistence, called the Last Gift study.

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

A Transgender Woman's Perspective on HIV Research, Prevention, and Care

Dr Sara Gianella talks with Brooke Sullivan, a transgender woman and HIV activist, about ways to improve transgender individuals' involvement in HIV research.

PrEP in the Transgender Population: New Study to Examine Effects

PrEP in the Transgender Population: New Study to Examine Effects

Dr Sara Gianella talks with Dr Sheldon Morris, from the University of California San Diego AntiViral Research Center about an upcoming PrEP study in transgender people, including understanding HIV prevention in this population, uptake of PrEP, and adherence to treatment.

HIV Transmission Through Breastfeeding: New Review and Expert Interview

HIV Transmission Through Breastfeeding: New Review and Expert Interview

Mother-to-child HIV transmission rates are low in the presence of antiretroviral therapy but increase once ART stops at 6 months postpartum.

Cardiovascular Disease in Persons With HIV Infection

Cardiovascular Disease in Persons With HIV Infection

Persons living with HIV infection have a higher risk for cardiovascular disease; use of some antiretroviral agents can exacerbate this risk.

Should the FDA Lift the Ban on Blood Donations From MSM?

Should the FDA Lift the Ban on Blood Donations From MSM?

Critics of the FDA's current restriction on blood donation from MSM argue that it is unnecessary and discriminatory, and propose a policy based on individual risk rather than sexual orientation.

HIV Research in Women: Expert Q&A

HIV Research in Women: Expert Q&A

Drs Gianella and Karris discuss the many factors that play a role in the underrepresentation of women in HIV research.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS